Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine Supplementation for Muscular Performance
NCT00785811Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Oct 2008
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial comparing L-arginine aspartate with Placebo (2 arms). Primary endpoint: Fatigue Resistance Factor. Started Oct 2008; status: terminated.
02
Drugs
L-arginine + aspartate
Beyond the preview
Go deeper on NCT00785811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00785811.